Association between DCK 35708 T>C Variation and Clinical Outcomes of Acute Myeloid Leukemia in South Chinese Patients

References

• Schlenk RF , DohnerH . Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia . Hematology Am. Soc. Hematol. Educ. Program2013 , 324 – 330 ( 2013 ).
   PubMedGoogle Scholar
• Grove CS , VassiliouGS . Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?Dis. Model. Mech.7 ( 8 ), 941 – 951 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kronke J , BullingerL , TeleanuVet al. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia . Blood122 ( 1 ), 100 – 108 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Souza Melo CP , CamposCB , DutraAPet al. Correlation between FLT3-ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias . Leuk. Res.39 ( 2 ), 131 – 137 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bacher U , SchnittgerS , MacijewskiKet al. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity . Blood119 ( 20 ), 4719 – 4722 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gaidzik VI , SchlenkRF , MoschnySet al. Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German–Austrian AML Study Group . Blood113 ( 19 ), 4505 – 4511 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network . Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia . N. Engl. J. Med.368 ( 22 ), 2059 – 2074 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Santamaria CM , ChillonMC , Garcia-SanzRet al. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia . Blood114 ( 1 ), 148 – 152 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Pastore F , DufourA , BenthausTet al. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia . J. Clin. Oncol.32 ( 15 ), 1586 – 1594 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Emadi A , KarpJE . The clinically relevant pharmacogenomic changes in acute myelogenous leukemia . Pharmacogenomics13 ( 11 ), 1257 – 1269 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lamba JK , CrewsKR , PoundsSBet al. Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes . Pharmacogenomics12 ( 3 ), 327 – 339 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang JJ , SelawryOS , ViettiTJ , BodeyGPSr . Prolonged infusion of arabinosyl cytosine in childhood leukemia . Cancer25 ( 1 ), 1 – 6 ( 1970 ).
   PubMed Web of Science ®Google Scholar
• Neubauer A , MaharryK , MrozekKet al. Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study . J. Clin. Oncol.26 ( 28 ), 4603 – 4609 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ustun C , MarcucciG . Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia . Curr. Opin. Hematol.22 ( 2 ), 85 – 91 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Braunagel D , SchaichM , KramerM , DransfeldCL , EhningerG , MahlknechtU . The T_T genotype within the NME1 promoter single nucleotide polymorphism -835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia . Leuk. Lymphoma53 ( 5 ), 952 – 957 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shi JY , ShiZZ , ZhangSJet al. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients . Pharmacogenetics14 ( 11 ), 759 – 768 ( 2004 ).
   PubMedGoogle Scholar
• Raza A , GezerS , AndersonJet al. Relationship of (3H)Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study . Exp. Hematol.20 ( 10 ), 1194 – 1200 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Lamba JK , CrewsK , PoundsSet al. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants . J. Pharmacol. Exp. Ther.323 ( 3 ), 935 – 945 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Yamauchi T , NegoroE , KishiSet al. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5′-nucleotidase II expression ratio in primary acute myeloid leukemia cells . Biochem. Pharmacol.77 ( 12 ), 1780 – 1786 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Galmarini CM , ThomasX , GrahamKet al. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine . Br. J. Haematol.122 ( 1 ), 53 – 60 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Abraham A , VaratharajanS , KarathedathSet al. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia . Pharmacogenomics16 ( 8 ), 877 – 890 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Stam RW , Den BoerML , MeijerinkJPet al. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia . Blood101 ( 4 ), 1270 – 1276 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Song JH , KimSH , KweonSHet al. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells . Int. J. Oncol.34 ( 4 ), 1165 – 1171 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wan H , ZhuJ , ChenFet al. SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study . J. Exp. Clin. Cancer Res.33 ( 1 ), 90 ( 2014 ).
   PubMedGoogle Scholar
• Amaki J , OnizukaM , OhmachiKet al. Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy . Int. J. Hematol.101 ( 6 ), 543 – 553 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang DY , YanH , CaoSet al. Wilms Tumor 1 rs16754 predicts favorable clinical outcomes for acute myeloid leukemia patients in south Chinese population . Leuk. Res.39 ( 6 ), 568 – 574 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kuendgen A , GermingU . Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly . Cancer Treat. Rev.35 ( 2 ), 97 – 120 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Cheson BD , BennettJM , KopeckyKJet al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia . J. Clin. Oncol.21 ( 24 ), 4642 – 4649 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Grimwade D , HillsRK , MoormanAVet al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials . Blood116 ( 3 ), 354 – 365 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Foran JM . New prognostic markers in acute myeloid leukemia: perspective from the clinic . Hematology Am. Soc. Hematol. Educ. Program2010 , 47 – 55 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• O’Donnell MR . Risk stratification and emerging treatment strategies in acute myeloid leukemia . J. Natl Compr. Canc. Netw.11 ( Suppl. 5 ), 667 – 669 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sun T , ZhouJP , KuangDBet al. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity . Am. J. Hypertens.26 ( 12 ), 1437 – 1444 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Shi YY , HeL . SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci . Cell Res.15 ( 2 ), 97 – 98 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Paschka P , DohnerK . Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?Hematology Am. Soc. Hematol. Educ. Program2013 , 209 – 219 ( 2013 ).
   PubMedGoogle Scholar
• Van Den Heuvel-Eibrink MM , WiemerEA , KuijpersM , PietersR , SonneveldP . Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML) . Leukemia15 ( 5 ), 855 – 856 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Joerger M , BoschTM , DoodemanVD , BeijnenJH , SmitsPH , SchellensJH . Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers . Eur. J. Clin. Pharmacol.62 ( 8 ), 681 – 684 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kim KI , HuhIS , KimIWet al. Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients . Eur. J. Cancer49 ( 2 ), 403 – 410 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Falk IJ , FyrbergA , PaulEet al. Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5′-nucleotidase . Am. J. Hematol.88 ( 12 ), 1001 – 1006 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Appelbaum FR , GundackerH , HeadDRet al. Age and acute myeloid leukemia . Blood107 ( 9 ), 3481 – 3485 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Xu J , ChenT , LiuYet al. Easily manageable prognostic factors in 152 Chinese elderly acute myeloid leukemia patients: a single-center retrospective study . J. Biomed. Res.28 ( 5 ), 396 – 405 ( 2014 ).
   PubMedGoogle Scholar
• Abraham A , DevasiaAJ , VaratharajanS , KarathedathS , BalasubramanianP , MathewsV . Effect of cytosine arabinoside metabolizing enzyme expression on drug toxicity in acute myeloid leukemia . Ann. Hematol.94 ( 5 ), 883 – 885 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gabor KM , SchermannG , Lautner-CsorbaOet al. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia . Pediatr. Blood Cancer62 ( 4 ), 622 – 628 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Medina-Sanson A , Ramírez-PachecoA , Moreno-GuerreroSS , Dorantes-AcostaEM , Sánchez-PrezaM , Reyes-LópezA . Role of genetic polymorphisms of deoxycytidine kinase and cytidine deaminase to predict risk of death in children with acute myeloid leukemia . Biomed. Res. Int.2015 , 1 – 10 ( 2015 ).
   Web of Science ®Google Scholar
• Doshi AA , ZioloMT , WangH , BurkeE , LesinskiA , BinkleyP . A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium . J. Card. Fail.16 ( 4 ), 314 – 319 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• National Institute of Environmental Health Sciences . http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm
   Google Scholar
• Campos-Melo D , DroppelmannCA , HeZ , VolkeningK , StrongMJ . Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels . Mol. Brain6 , 26 ( 2013 ).
   PubMed Web of Science ®Google Scholar